Zobrazeno 1 - 10
of 39
pro vyhledávání: '"BENJAMIN P. SOULE"'
Autor:
Paul Emery, Yoshiya Tanaka, Vivian P. Bykerk, Thomas W. J. Huizinga, Gustavo Citera, Clifton O. Bingham, Subhashis Banerjee, Benjamin P. Soule, Marleen Nys, Sean E. Connolly, Karissa L. Lozenski, Joe Zhuo, Robert Wong, Kuan-Hsiang Gary Huang, Roy Fleischmann
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 3, Pp 707-727 (2023)
Abstract Introduction One target of rheumatoid arthritis (RA) treatment is to achieve early sustained remission; over the long term, patients in sustained remission have less structural joint damage and physical disability. We evaluated Simplified Di
Externí odkaz:
https://doaj.org/article/031a80a1de6645ab8805525b4951051a
Autor:
Anthony D. Saleh, Jason E. Savage, Liu Cao, Benjamin P. Soule, David Ly, William DeGraff, Curtis C. Harris, James B. Mitchell, Nicole L. Simone
Publikováno v:
PLoS ONE, Vol 7, Iss 4 (2012)
Externí odkaz:
https://doaj.org/article/361a1237f7da449ab55c98bb827fc767
Autor:
John B Buse, Helene Nordahl Christensen, Brian J Harty, Julie Mitchell, Benjamin P Soule, Emily Zacherle, Mark Cziraky, Vincent J Willey
Publikováno v:
BMJ Open Diabetes Research & Care. 11:e003206
IntroductionOnce-weekly subcutaneous semaglutide, a glucagon-like peptide-1 analog, is approved in the USA as an adjunct to diet and exercise for adults with inadequately controlled type 2 diabetes (T2D) to improve glycemic control and reduce the ris
Autor:
VINCENT WILLEY, JOHN B. BUSE, BRIAN HARTY, JULIE L. MITCHELL, BENJAMIN P. SOULE, HELENE N. CHRISTENSEN, MARK J. CZIRAKY, SIMON SKIBSTED
Publikováno v:
Diabetes. 71
SEPRA (NCT03596450) is a 2-yr, multicenter, open-label, randomized pragmatic clinical trial comparing the long-term effects of once-weekly subcutaneous semaglutide vs. standard of care (both added to ≤2 oral antidiabetic medications) in US health-i
Autor:
Nicholas G. Zaorsky, Benjamin P. Soule, Brittany A. Simone, Joshua D. Palmer, Nicole L. Simone, Lianjin Jin
Publikováno v:
Ageing Research Reviews. 17:16-24
As the link between metabolism and major disease processes becomes more well-defined, the identification of key molecular targets is leading to new therapeutic strategies. As a result, small non-coding RNA molecules that regulate gene expression via
Autor:
Nitin Ohri, J.B. Mitchell, David Ly, S. L. Smith, Kevin Camphausen, Nicole L. Simone, Marc E. Lippman, K. Matsuda, Stephen M. Hewitt, Tu Dan, Benjamin P. Soule, Uma Shankavaram
Publikováno v:
Breast Cancer Res Treat
CD44 is a transmembrane glycoprotein involved in numerous cellular functions, including cell adhesion and extracellular matrix interactions. It is known to be functionally diverse, with alternative splice variants increasingly implicated as a marker
Autor:
Mark S. Litwin, Anurag K. Singh, Benjamin P. Soule, Nicole L. Simone, Janet E. Cowan, Peter R. Carroll
Publikováno v:
Journal of Urology. 180:2447-2452
Most men diagnosed with prostate cancer will die of other causes and pretreatment patient characteristics may identify those who are likely to die of other causes. Accurate stratification of patients by risk of other cause mortality may reduce needle
Autor:
John A. Cook, Nicole L. Simone, Murali C. Krishna, Benjamin P. Soule, Fuminori Hyodo, James B. Mitchell, Ken-ichiro Matsumoto
Publikováno v:
Antioxidants & Redox Signaling. 9:1731-1744
Nitroxide compounds have been used for many years as biophysical tools, but only during the past 15-20 years have the many interesting biochemical interactions been discovered and harnessed for therapeutic applications. By modifying oxidative stress
Autor:
Benjamin P. Soule, Nicole L. Simone, Paul S. Albert, Anurag K. Singh, Austin John Barrett, Bipin N. Savani, H Ning
Publikováno v:
Bone Marrow Transplantation. 40:573-578
Our purpose was to determine if total body irradiation (TBI) with lung dose reduction protects against subsequent radiation-induced deterioration in pulmonary function. Between July 1997 and August 2004, 181 consecutive patients with hematologic mali
Autor:
James B. Mitchell, Murali C. Krishna, Nicole L. Simone, Fuminori Hyodo, Ken-ichiro Matsumoto, John A. Cook, Benjamin P. Soule
Publikováno v:
Free Radical Biology and Medicine. 42:1632-1650
Cyclic nitroxides are a diverse group range of stable free radicals that have unique antioxidant properties. Because of their ability to interact with free radicals, they have been used for many years as biophysical tools. During the past 15-20 years